Clarity Pharma (CU6) is held by 6 ASX ETFs. Over the last year it fell 60.1%: on $10,000, −$6007. We explain 9 big moves in that time.
About CU6
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$716.3m
- Held by6 ETFs
- Big moves9 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- −5.9%peak −6.4%9 Oct 2026· Operational
Clarity Pharmaceuticals likely fell on profit-taking or disappointment after news of achieving its SECuRE cohort recruitment target failed to sustain the prior rally, with no new positive catalyst to drive further gains.
- +7.1%peak +15.5%5 Aug 2026· Sector Flow
CU6 rose sharply alongside a broader rally in Australian healthcare stocks, lifting the stock well above its normal daily range.
- −9.1%peak −10.3%7 Jul 2026· Unknown
Clarity Pharmaceuticals (CU6) fell sharply as investors sold into the stock after a near-15% rally the prior day, with no new positive catalysts to sustain the move and news articles specifically questioning the reasons behind the sell-off
- +19.0%peak +19.9%6 Jul 2026· Sector Flow
Clarity Pharmaceuticals rallied ~15% driven by renewed investor interest in the radiopharmaceutical sector, with market attention focusing on the company as a precision oncology developer amid a broader 'hot' radiopharma theme.
- +15.7%29 Jun 2026· Sector Flow
Clarity Pharmaceuticals' share price surged due to a broader sector flow into ASX biotech stocks, with the company set to present prostate cancer data at the EANM conference soon after.
- −11.0%26 Jun 2026· Stake Change
A substantial holder notice ceasing their holding in Clarity Pharmaceuticals triggered the stock decline, likely due to a major shareholder selling down their stake.
- +7.9%15 Apr 2026· Operational
Clarity Pharmaceuticals' share price rose 7.9% on April 15, 2026, likely recovering from a previous day's 5% drop following a manufacturing expansion announcement.
- +24.8%16 Feb 2026· Operational
Clarity Pharmaceuticals likely surged on a breakthrough moment in its radiopharmaceutical pipeline, as highlighted in subsequent news coverage.
- +15.1%16 Oct 2025· Contract
Clarity Pharmaceuticals announced a copper-67 supply agreement with Nusano, likely boosting investor confidence.
Held by 6 ETFs
Of every $10,000 in each fund, how much is in CU6 today.
- SSOSTATE STREET SPDR S&P/ASX SMALL ORDINARIES ETF$240.24%
- ISOiShares S&P/ASX Small Ordinaries ETF$240.24%
- VSOVanguard MSCI Australian Small Companies Index ETF$110.11%
- VETHVanguard Ethically Conscious Australian Shares ETF$3.360.03%
- VASVanguard Australian Shares Index ETF$2.740.03%
- A300Global X Australia 300 ETF$2.410.02%